Home
Resources
Diseases
Compendium
Training
Evaluation
The Tool
The Tutorial
SYSVAC
About
Registry
E-learning courses
News
Webinars
Network
Steering Committee
Vision and Mission
Map
Meetings
Partners
Join us
Home
Resources
Resources
Type of publications
Guidelines (30)
NITAG documentation (1591)
Reports (55)
SAGE documentation (222)
Scientific publications (112)
Systematic reviews (SYSVAC) (2750)
Regions
Africa (267)
Americas (762)
Eastern Mediterranean (48)
Europe (704)
South-East Asia (78)
Western Pacific (196)
Diseases
Chikungunya (9)
Cholera (33)
COVID-19 (1481)
Cytomegalovirus (1)
Dengue (39)
Diphtheria (79)
Ebola (16)
Escherichia coli (ETEC) (2)
Haemophilus influenzae type B (66)
Hepatitis A (63)
Hepatitis B (153)
Hepatitis C (4)
Hepatitis E (5)
Herpes simplex (1)
Herpes zoster (66)
HIV / AIDS (10)
Human papillomavirus (HPV) (472)
Influenza (573)
Japanese encephalitis (34)
Lyme disease, Borreliosis (1)
Malaria (27)
Measles (128)
Meningococcal disease (145)
Mpox (55)
Mumps (46)
Pertussis (104)
Pneumococcal disease (270)
Poliomyelitis (84)
Q fever (1)
Rabies (28)
Rotavirus (115)
RSV (Respiratory syncytial virus) (47)
Rubella (64)
Salmonella (2)
Shigella (1)
Smallpox (16)
Streptococcus group B (6)
Tetanus (59)
Tick-borne encephalitis (12)
Tuberculosis (73)
Typhoid (23)
Varicella (69)
Yellow fever (42)
Zika (1)
Show more
4760 results found
2006
Vaccination against Seasonal Flu (Winter 2006 - 2007)
2006
∙
Armand Biver
Vaccination of infants against rotavirus gastroenteritis
2006
∙
Conseil Supérieur de la Santé (CSS)
Vaccination strategy for the Pneumococcal Conjugate Vaccine
2005
∙
ACIP
A Comprehensive Immunization Strategy to Eliminate Transmission of Hepatitis B Virus Infection in the United States - Part 1: Immunization of Infants, Children, and Adolescents
2005
∙
L.J. Erickson, Philippe De Wals, L Farand
An analytical framework for immunization programs in Canada
2005
∙
CFV/EKIF
Declaration of interests for members of the Federal Vaccination Commission
2005
Extanded Vaccination Strategy against Seasonal Flu
2005
∙
ACIP
FDA Approval of Havrix® (Hepatitis A Vaccine, Inactivated) for Persons Aged 1--18 Years
2005
∙
ACIP
FDA Approval of VAQTA® (Hepatitis A Vaccine, Inactivated) for Children Aged >1 Year
2005
∙
ACIP
Licensure of a Combined Live Attenuated Measles, Mumps, Rubella, and Varicella Vaccine
Home
Resources
Diseases
Compendium
Training
Evaluation
SYSVAC
News
Webinars
Network
Sign in / Register